Bristol-Myers Squibb Co vs DigitalOcean Holdings Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $132.45B), while DigitalOcean Holdings Inc trades at $122.34 (market cap $15.25B). The key difference: Bristol-Myers Squibb Co is far larger — about 8.7× DigitalOcean Holdings Inc's market cap, and Bristol-Myers Squibb Co pays a 3.89% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals.
| BMY | DOCN | |
|---|---|---|
Market Cap | $132.45B | $15.25B |
Sector | Health | Technology |
52-Week High | $65.89 | $181.29 |
52-Week Low | $42.60 | $29.99 |
Enterprise Value | $166.44B | $16.02B |
Dividend Yield | 3.89% | — |
Trailing returns across standard periods
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →